Xiao-Yu Yin

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ying‐Qin Zhu · 7 shared papers, 2024–2026 · strength 1.60
   • Paper CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancre… DOI 10.1002/ctm2.70776↗
   • Paper Positive Feedback Loop of Histone Lactylation-Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcino… DOI 10.1002/advs.202510483↗
   • Paper Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.canlet.2025.218058↗
2. Mingjian Ma · 7 shared papers, 2024–2026 · strength 1.60
   • Paper CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancre… DOI 10.1002/ctm2.70776↗
   • Paper Positive Feedback Loop of Histone Lactylation-Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcino… DOI 10.1002/advs.202510483↗
   • Paper Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.canlet.2025.218058↗
3. Xi‐Tai Huang · 8 shared papers, 2018–2026 · strength 1.56
   • Paper Synergistic Induction of Ferroptosis by GPX4 Inhibitor and GSH-Depleted Nanoparticles Effectively Reverses Gemcitabine … DOI 10.1002/adhm.202503694↗
   • Paper Positive Feedback Loop of Histone Lactylation-Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcino… DOI 10.1002/advs.202510483↗
   • Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
4. Zhide Liu · 6 shared papers, 2024–2026 · strength 1.31
   • Paper CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancre… DOI 10.1002/ctm2.70776↗
   • Paper Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.canlet.2025.218058↗
   • Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
5. Chen‐Song Huang · 5 shared papers, 2018–2026 · strength 1.06
   • Paper Remote robot-assisted pancreatoduodenectomy for one patient with pancreatic ductal adenocarcinoma. DOI 10.21037/hbsn-2025-1-913↗
   • Paper Synergistic Induction of Ferroptosis by GPX4 Inhibitor and GSH-Depleted Nanoparticles Effectively Reverses Gemcitabine … DOI 10.1002/adhm.202503694↗
   • Paper Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Duc… DOI 10.1002/advs.202406714↗
6. Jie‐Qin Wang · 5 shared papers, 2024–2026 · strength 1.04
   • Paper Synergistic Induction of Ferroptosis by GPX4 Inhibitor and GSH-Depleted Nanoparticles Effectively Reverses Gemcitabine … DOI 10.1002/adhm.202503694↗
   • Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
   • Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
7. Yin-Hao Shi · 4 shared papers, 2024 · strength 0.75
   • Paper N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma ge… DOI 10.1038/s41388-024-03092-3↗
   • Paper Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP… DOI 10.1002/advs.202407069↗
   • Paper Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Duc… DOI 10.1002/advs.202406714↗
8. Wei Zhao · 5 shared papers, 2018–2024 · strength 0.75
   • Paper CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy. DOI 10.1016/j.canlet.2024.216640↗
   • Paper SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. DOI 10.1038/s41418-023-01175-4↗
   • Paper ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pan… DOI 10.1016/j.canlet.2022.215802↗
9. Xiao‐Xu Zhu · 4 shared papers, 2018–2023 · strength 0.57
   • Paper SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. DOI 10.1038/s41418-023-01175-4↗
   • Paper ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pan… DOI 10.1016/j.canlet.2022.215802↗
   • Paper HNRNPC impedes m6A-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2021.07.016↗
10. De-Liang Fang · 2 shared papers, 2025–2026 · strength 0.56
    • Paper CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancre… DOI 10.1002/ctm2.70776↗
    • Paper Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.canlet.2025.218058↗
11. Siyuan Lu · 2 shared papers, 2025–2026 · strength 0.56
    • Paper CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancre… DOI 10.1002/ctm2.70776↗
    • Paper Auranofin facilitates gemcitabine sensitivity by regulating TXNRD1-related ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.canlet.2025.218058↗
12. Ya-Xiong Li · 2 shared papers, 2022–2023 · strength 0.34
    • Paper SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. DOI 10.1038/s41418-023-01175-4↗
    • Paper ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pan… DOI 10.1016/j.canlet.2022.215802↗
13. Xiao Feng Wu · 2 shared papers, 2022–2023 · strength 0.34
    • Paper SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. DOI 10.1038/s41418-023-01175-4↗
    • Paper ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pan… DOI 10.1016/j.canlet.2022.215802↗
14. Xuhao Ni · 2 shared papers, 2022–2023 · strength 0.34
    • Paper SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. DOI 10.1038/s41418-023-01175-4↗
    • Paper ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pan… DOI 10.1016/j.canlet.2022.215802↗
15. Rong Tang · 1 shared paper, 2026 · strength 0.24
    • Paper Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in p… DOI 10.1038/s41467-026-73702-z↗
16. Qiong Du · 1 shared paper, 2026 · strength 0.24
    • Paper Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in p… DOI 10.1038/s41467-026-73702-z↗
17. Liquan Jin · 1 shared paper, 2026 · strength 0.24
    • Paper Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in p… DOI 10.1038/s41467-026-73702-z↗
18. Xianjun Yu · 1 shared paper, 2026 · strength 0.24
    • Paper Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in p… DOI 10.1038/s41467-026-73702-z↗
19. Chenghao Shao · 1 shared paper, 2026 · strength 0.24
    • Paper Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in p… DOI 10.1038/s41467-026-73702-z↗
20. Si Shi · 1 shared paper, 2026 · strength 0.24
    • Paper Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in p… DOI 10.1038/s41467-026-73702-z↗
21. Yue Huang · 1 shared paper, 2024 · strength 0.18
    • Paper Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Duc… DOI 10.1002/advs.202406714↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.